ArticleCancer discovery2021

CARM1 Inhibition Enables Immunotherapy of Resistant Tumors by Dual Action on Tumor Cells and T Cells.

Sushil Kumar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.